First Trust Advisors
NVAX icon

First Trust Advisors’s Novavax NVAX Stock Holding History

First Trust Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Buy
409,328
+112,009
+38% +$1.02M ﹤0.01% 1681
2025
Q4 		$2M Buy
297,319
+102,328
+52% +$771K ﹤0.01% 1884
2025
Q3 		$1.69M Buy
194,991
+105,859
+119% +$824K ﹤0.01% 1910
2025
Q2 		$562K Buy
89,132
+11,251
+14% +$74.5K ﹤0.01% 2235
2025
Q1 		$499K Sell
77,881
-163,236
-68% -$1.35M ﹤0.01% 2241
2024
Q4 		$1.94M Buy
+241,117
New +$2.32M ﹤0.01% 1824
2023
Q2 		– Sell
-610,427
Closed -$4.23M – 2419
2023
Q1 		$4.23M Buy
+610,427
New +$5.62M ﹤0.01% 1314
2022
Q2 		– Sell
-14,310
Closed -$1.05M – 2569
2022
Q1 		$1.05M Sell
14,310
-136,220
-90% -$12.1M ﹤0.01% 2032
2021
Q4 		$21.5M Sell
150,530
-140,621
-48% -$24.2M 0.02% 818
2021
Q3 		$60.4M Buy
291,151
+203,135
+231% +$44.8M 0.06% 407
2021
Q2 		$18.7M Buy
88,016
+57,354
+187% +$10.5M 0.02% 804
2021
Q1 		$5.56M Sell
30,662
-5,396
-15% -$1.08M 0.01% 1168
2020
Q4 		$4.02M Buy
+36,058
New +$3.83M 0.01% 1189
2016
Q4 		– Sell
-179,534
Closed -$7.47M – 2481
2016
Q3 		$7.47M Sell
179,534
-82,875
-32% -$10.7M 0.02% 822
2016
Q2 		$38.2M Buy
262,409
+29,165
+13% +$3.34M 0.12% 185
2016
Q1 		$24.1M Sell
233,244
-443,038
-66% -$47.5M 0.08% 327
2015
Q4 		$113M Buy
676,282
+142,838
+27% +$22M 0.29% 68
2015
Q3 		$75.4M Sell
533,444
-186,595
-26% -$41.8M 0.22% 100
2015
Q2 		$160M Buy
720,039
+14,137
+2% +$2.48M 0.42% 31
2015
Q1 		$117M Buy
+705,902
New +$115M 0.34% 49

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors's NVAX Position: Q1 2026 in Review

First Trust Advisors increased its Novavax (NVAX) stake by 38% in Q1 2026, buying an estimated $1.02M and bringing the position to 409,328 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

First Trust Advisors first reported a position in NVAX in Q1 2015 and has held it in 20 quarters since. The position peaked at $160M in Q2 2015. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • First Trust Advisors held 409,328 shares of Novavax worth $3.33M as of Q1 2026.
  • First Trust Advisors bought 112,009 Novavax shares in Q1 2026, an estimated $1.02M.
  • Novavax made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #1681 holding.
  • First Trust Advisors first reported a position in Novavax in Q1 2015 and has held it in 20 quarters since.
  • First Trust Advisors's Novavax position peaked at $160M in Q2 2015.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.